Richard L. Kravitz, MD, MSPH and Jodi Halpern, MD, PhD
Patients have a responsibility to discerningly present the drug information they receive from direct-to-consumer advertising and to be active partners with their physician in making health care decisions.
Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
Dr Noah Boton joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Larnard: “When Should Patients at the End of Life Get Antimicrobials?”
In a study of New York physicians' compliance with reporting of communicable diseases, surveyed physicians responded better to legal warnings than to requests that explained public health benefits.
Clinical case examines physicians’ duties and risks during an epidemic. Commentaries address physician’s rights vs patients’ rights. Does the duty to treat always override personal or family concerns?
In quarantine situations, the actions of autonomous individuals are restricted to protect the health of the public. Physicians enforcing quarantine should be sympathetic and clear in communicating with those whose activities are being restricted.